We provide support for people with Type 2 Diabetes, Fatty Liver, Infertility, Erectile Dysfunction, Hypothyroidism, Hyperthyroidism, PCOS, Hirsutism, Adrenal Dysfunction, Menopause, Pituitary problems, Sexual Dysfunction, infertility and Osteoporosis
This was the paradoxical effect, a net rise of intraocular pressure, and impaired uveoscleral outflow in the condition of the severely compromised and unresponsive trabecular outflow [63]
If a plateau extends beyond 6 weeks and you are not yet at maximum dose, escalating to the next dose level is the standard approach
Ramdas WD, Wolfs RCW, Hofman A, De Jong PTVM, Vingerling JR, Jansonius NM
What to expect: Once-weekly injection under the skin Dose is gradually increased over several months Average weight loss of 2022% of body weight currently the most effective approved weight loss medication available Particularly effective at reducing dangerous fat around the organs (visceral fat) and under the skin (subcutaneous fat) Additional benefit Fatty Liver Disease: Both medications reduce visceral fat but tirzepatide's additional GIP action appears to target fat tissue more powerfully, particularly fat stored around the organs (visceral fat) and under the skin (subcutaneous fat), resulting in greater overall fat loss relative to weight lost
